Business news – Page 31
-
BusinessEU commits to overhaul of chemicals legislation
The Chemicals Strategy for Sustainability promises the biggest reform since Reach
-
BusinessCovid-19 highlights need to update pharma supply chains
Resilience and redundancy are key amid protectionist calls for domestic manufacturing
-
OpinionThe Nobel prize that got binned
Ferrocene is a classic example of a discovery that was dismissed as a failed experiment
-
BusinessArkema acquitted over hurricane fire emissions
US Judge rules there is insufficient evidence to bring criminal charges relating to peroxide fire caused by flooding in 2017
-
OpinionBlood offering
Antibodies in various forms could bridge the Covid-19 treatment gap until a vaccine is available
-
NewsEnvironmental groups propose tax on basic chemical manufacturing
A coordinated 0.5% fee on chemical feedstocks could generate $11.5bn to fund chemicals and waste management globally
-
BusinessCovid-19 vaccine deals risk skewing supply
International accords including Covax aiming to ensure equitable distribution to poorer countries
-
OpinionJumping the vaccine queue
Deals between companies and rich governments offset manufacturing risks, but must not compromise supplies to those in need
-
BusinessProtein-based Covid-19 vaccines could overshadow rivals
Although slower to develop, protein-based vaccines are well understood with a strong record of safety and effectiveness
-
BusinessRosa Biotech gets biosensors on the nose
Protein barrel arrays mimic mammals’ olfactory system to distinguish many different molecules
-
BusinessRussian Covid-19 vaccine data raises questions
Suspected data manipulation or fabrication casts shadows over safety trial report for hastily-approved Sputnik V
-
BusinessDrop in plasma donations hits immunoglobulin supply
Lockdown and social distancing have discouraged donors, and the potential impact of convalescent plasma collection for Covid-19 treatment is unclear
-
ArticleExploring the advantages of single-crystal x-ray diffraction in pharma
Single-crystal x-ray diffraction (SCXRD) in drug development is evolving. Johnson Matthey outlines how technology advances and regulations are reshaping its role in pharma
-
BusinessUncovering the sources of contaminated sanitisers
Methanol and 1-propanol could get into hand gels by unintentional or deliberate adulteration
-
OpinionFacing the challenge of vaccine trials
Russia’s Covid-19 gamble is a stark contrast to even accelerated clinical programmes
-
OpinionFrom collaboration to collusion
The US government’s crackdown on academics not declaring Chinese funding highlights a moral hazard
-
NewsEPA rescinds methane emissions reduction rule
Obama-era regulations have been rolled back at the EPA, to the chagrin of some big oil firms and environmental groups
-
BusinessOvercoming hydrogen hype
European strategies set up hydrogen’s potential contribution to lowering carbon emissions
-
BusinessRussian vaccine launch shocks scientists
Sputnik V to be approved without large human trial data
-
BusinessEncouraging signs from initial Covid-19 vaccine trials
Human trials deliver positive immune responses, while primate challenge studies suggest protection is possible